Search Results 191-200 of 15942 for syphilis

  1. Overview - Division of Infectious Diseases - Mayo Clinic Research

    Mayo Clinic's world-renowned infectious disease researchers study new antimicrobics, investigate patterns and mechanisms of antimicrobial resistance, track ...

  2. Trichinosis - Symptoms & causes - Mayo Clinic

    When humans eat raw or undercooked meat containing trichinella larvae, the larvae grow into adult worms in the small intestine. This takes several weeks. The ...

  3. Plague - Symptoms and causes - Mayo Clinic

    Plague is a serious illness caused by a germ called Yersinia pestis. The germs mostly live in small rodents and their fleas. The most common way for humans to ...

  4. A Study to Find RNA Markers that Describe the Underlying Inflammatory Process and Can Help Direct Therapy - Mayo Clinic

    The purpose of the study is to find specific and sensitive RNA markers that not only describe the underlying inflammatory process, but can help direct therapy ...

  5. Mononucleosis - Symptoms & causes - Mayo Clinic

    Infectious mononucleosis (mono) is often called the kissing disease. The virus that causes mono (Epstein-Barr virus) is spread through saliva.

  6. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

    Human immunodeficiency virus 1 (HIV 1), HIV 2, or syphilis positive (rapid plasma reagin [RPR]); Active hepatitis B surface antigen (HBsAg) or hepatitis C ...

  7. AUTO1 in Relapsed or Refractory B-ALL - Mayo Clinic

    Human Immunodeficiency Virus (HIV), human T-cell lymphotropic virus (HTLV)-1, HTLV-2, or syphilis positive test. Patients who have received a prior stem ...

  8. Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study - Mayo Clinic

    The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients ...

  9. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...

  10. Fecal Microbiota Transplant National Registry - Mayo Clinic

    About this study. A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to ...